Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis

Fig. 2

Forest plots. A. Change of BCVA between aflibercept and ranibizumab groups. B. Change of the height of PED between aflibercept and ranibizumab. C. The proportion of patients without PED at follow-up between aflibercept and ranibizumab. IVA: intravitreal aflibercept, IVR: intravitreal ranibizumab

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us